Le Lézard
Classified in: Health
Subject: FEA

Vitrolife´s CFO leaves


GOTHENBURG, Sweden, Sept. 2, 2021 /PRNewswire/ -- Vitrolife's Chief Financial Officer (CFO) Mikael Engblom has today resigned from his position. A process to recruit a replacement will be initiated and Mikael Engblom will continue in his current role until a new CFO takes office. Mikael Engblom has been CFO since 2011 and before that worked as a controller at the company.

"During his time as CFO, Mikael has played a key role in transforming the company from a small niche company to a very profitable market-leading player in reproductive health with an international ownership base through internal efficiency work, strategy plans and acquisitions," says Thomas Axelsson, CEO. "I would like to thank Mikael for good cooperation and his valuable contribution to the company's exceptional development over the past ten years and wish him best of luck for the future," says Thomas Axelsson, CEO.

"Vitrolife is facing a new exciting growth journey, but after ten developing years as CFO at Vitrolife, I have decided that it is time for a new challenge," says Mikael Engblom.

Gothenburg, September 2, 2021
VITROLIFE AB (publ)
Thomas Axelsson, CEO

CONTACT:

Queries should be addressed to:

Thomas Axelsson, CEO, tel 46 31 721 80 01

Mikael Engblom, CFO, tel 46 31 721 80 14

The information was submitted for publication, through the agency of the contact person set out above, at 3.00 pm CET on September 2, 2021.

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab--publ-/r/vitrolife-s-cfo-leaves,c3408643

The following files are available for download:

https://mb.cision.com/Main/1031/3408643/1463335.pdf

Vitrolife´s CFO leaves

SOURCE Vitrolife AB (publ)


These press releases may also interest you

at 08:50
Agilent Names Simon May to Lead Diagnostics and Genomics Group
Agilent Technologies, Inc. today announced Simon May has been named president of the company's Diagnostics and Genomics Group (DGG). May, previously executive vice president and president of the Life Science Group at Bio-Rad Laboratories, will join...

at 08:50
CARsgen Submitted Responses to FDA Observations
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that responses regarding the status of the Corrective and...

at 08:47
Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month
Lucid Diagnostics Inc.  ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. , is partnering with the Esophageal Cancer Action Network (ECAN) to highlight...

at 08:43
SYNEVIT® Applies the Concept of Continuous Improvement to Supplements
Continuous improvement is a popular concept in areas like academia and corporate America. It allows individuals and organizations to fine-tune processes, save time, and enhance results. SYNEVIT® is proving that this incremental enhancement is...

at 08:41
No Burps. Guaranteed. Arctic Blue Offers a Truly Non-Fishy Omega-3 Fish Oil
Fish oil supplements are a popular supplement option. They are rich in Omega-3 fatty acids and can contribute to the management of health concerns such as blood pressure and blood triglyceride levels. While effective as a health tool, though, there...

at 08:39
SG360° Secures Elite HITRUST Certification, Enhancing Data Security Standards
SG360°, a leading provider of integrated print and addressable marketing solutions, proudly announces it has achieved the highly esteemed HITRUST r2 certification. Recognized globally as the gold standard for data security, the HITRUST r2...

More news about Health...


News published on and distributed by: